Metabolism of toremifene in the rat
- PMID: 2142235
- DOI: 10.1016/0022-4731(90)90007-f
Metabolism of toremifene in the rat
Abstract
Toremifene was labelled to a specific activity of about 20 microCi/mmol with tritium at positions 3 and 5 in the para-substituted phenyl ring. At these positions tritium is not eliminated within the metabolic pathways. A mixture of unlabelled and labelled toremifene (5 or 10 mg/kg, 5 microCi/mg) was given i.v. or p.o. to Sprague-Dawley rats. The elimination of radioactivity was followed up by collecting urine and feces daily for 13 days. The elimination of toremifene which was similar after p.o. and i.v. administration took place mainly in the feces. About 70% of the total radioactivity was eliminated within 13 days, of this amount more than 90% in the feces. All applied radioactivity could be detected in three separate fractions according to the oxidative state of the side chain when counted by Berthold TLC Linear Analyzer. Each fraction was further separated into single metabolites by TLC or HPLC. Altogether 9 metabolites were identified and almost all methanol-extractable components were identified. The main metabolic pathways in the rat were 4-hydroxylation and N-demethylation. The side chain was further oxidized to alcohols and carboxylic acids. Small amounts of unchanged toremifene were found in the feces both after p.o. and i.v. administration indicating biliary secretion.
Similar articles
-
Pharmacokinetics of toremifene.J Steroid Biochem. 1990 Jun 22;36(3):249-52. doi: 10.1016/0022-4731(90)90019-o. J Steroid Biochem. 1990. PMID: 2142247
-
In vitro and in vivo binding of toremifene and its metabolites in rat uterus.J Steroid Biochem. 1990 Jun 22;36(3):197-202. doi: 10.1016/0022-4731(90)90004-c. J Steroid Biochem. 1990. PMID: 2142232
-
Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.Breast Cancer Res Treat. 2000 Mar;60(1):63-70. doi: 10.1023/a:1006311214152. Breast Cancer Res Treat. 2000. PMID: 10845810
-
Review of the pharmacological properties of toremifene.J Steroid Biochem. 1990 Jun 22;36(3):191-5. doi: 10.1016/0022-4731(90)90003-b. J Steroid Biochem. 1990. PMID: 2142231 Review.
-
[The anti-estrogenic effect of 4-chloro-1,2-diphenyl-1-(4-[2-(N,N-dimethylamino)ethoxy]phenyl)1-butene (Toremifene) on the endocrine regulation in breast cancer patients].Orv Hetil. 1991 Mar 31;132(13):683-6. Orv Hetil. 1991. PMID: 1826556 Review. Hungarian.
Cited by
-
DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver.Cancer Sci. 2006 Jun;97(6):468-77. doi: 10.1111/j.1349-7006.2006.00211.x. Cancer Sci. 2006. PMID: 16734724 Free PMC article.
-
Effect of toremifene on antipyrine elimination in the isolated perfused rat liver.Cancer Chemother Pharmacol. 1993;31(4):319-23. doi: 10.1007/BF00685678. Cancer Chemother Pharmacol. 1993. PMID: 8422697
-
Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.Clin Pharmacokinet. 1992 May;22(5):327-58. doi: 10.2165/00003088-199222050-00002. Clin Pharmacokinet. 1992. PMID: 1505141 Review.
-
Biochemical and pharmacological effects of toremifene metabolites.Cancer Chemother Pharmacol. 1990;27(1):8-12. doi: 10.1007/BF00689269. Cancer Chemother Pharmacol. 1990. PMID: 2147128
-
FDA-approved drugs containing dimethylamine pharmacophore: a review of the last 50 years.RSC Adv. 2024 Sep 2;14(38):27657-27696. doi: 10.1039/d4ra04730c. eCollection 2024 Aug 29. RSC Adv. 2024. PMID: 39224646 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources